BiotechTube
Home/Enthorin Therapeutics/Michael A. Yassa, Ph.D.
MA

Michael A. Yassa, Ph.D.

Co-Founder

Enthorin Therapeutics

Therapeutic Areas

Neurodevelopmental DisordersNeurodegenerative Diseases

Enthorin Therapeutics Pipeline

DrugIndicationPhase
ENT-3379Fragile X SyndromePhase 1
Platform AssetAutism Spectrum DisordersPre-clinical

Leadership Team at Enthorin Therapeutics

JG
J. Guy Breitenbucher, Ph.D.
Co-Founder
MP
Marco Peters, Ph.D.
Co-Founder
View full Enthorin Therapeutics profile